• BIA Blog

Guest Blog | All data matters and all matters data – how Health Data Research hubs are unlocking the power of data

In September this year, the seven initial Health Data Research Hubs celebrated their joint first birthday and reflected on their achievements over the past year. Set up as part of a four-year, £37 million investment from the UK Government Industrial Strategy Challenge Fund, the data hubs were designed to create a UK-wide system for the safe and responsible use of health-related data on a large scale.

CEO Update | Monday 11 January

This week’s CEO blog covers the largest acquisition of a privately listed UK biotech company on record, new positive analysis of biotech stocks, our preparations for the J.P. Morgan Healthcare conference, the latest on COVID-19 vaccinations and a look ahead to our first virtual event of the year based on work of member companies in the North West of England.

CEO Update | Monday 04 January

Happy New Year! 2021 got off to a promising start with the rollout of more innovative COVID-19 vaccines, sector recognition in the New Year Honours and we are now getting to grips with what the UK-EU deal will mean for our sector.

Guest Blog | Covid-19: is the vaccine race over?

The last few months have signalled hope that we might soon see the end of the Covid-19 pandemic. Many vaccine candidates released positive results and now the gradual roll out of the vaccine has begun. What about the others who were also part of the race? What does this mean for their efforts and essentially, is the vaccine race over?

CEO Update | Monday 14 December

“There are decades where nothing happens; and there are weeks where decades happen” sums up 2020 very well. In this blog I review the BIA’s work over the past twelve months, from innovating in the way we deliver events, to helping secure manufacturing facilities for COVID-19 vaccines, in a year that has been like no other.

BIA Brexit update

Steve Bates writes about the latest news of Brexit talks, as another deadline for a free trade deal between the Government and the European Union is missed. Steve also explores issues around marketing authorisation holder (MAH) and local representative naming, on product information for products on the Northern Ireland market.

CEO Update | Monday 07 December

This week the first approved vaccine for COVID-19 will be rolled out as the UK is the first country to authorise the Pfizer/BioNTech mRNA vaccine

Guest Blog | CF Foundation’s Path to a Cure Programme

Since the discovery of the gene that causes cystic fibrosis in 1989, advances in our understanding of CF have been profound. CFTR modulators, which address the underlying cause of CF by modifying the CFTR protein, are beginning to change what it means to have cystic fibrosis.

CEO Update | Monday 30 November

The initial rollout of a COVID-19 vaccine in the UK is getting very close indeed. To support this effort, the Government has appointed Nadim Zahawi MP as Minister for Vaccine Deployment in the Department of Health and Social Care (DHSC).

Spending review 2020 offers some reassurance to biotech sector but the Biomedical Catalyst remains unsecured

Amid gloomy economic predictions and rising public borrowing fuelled by the pandemic, the Chancellor delivered a one-year government spending settlement with investment in jobs and infrastructure to reassure a nervous nation.